← Evidence map

ArticleCell cycle (Georgetown, Tex.)2023

CCNE1 is a potential target of Metformin for tumor suppression of ovarian high-grade serous carcinoma.

Jie Mei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36004387